ArriVent BioPharma, Inc. (AVBP) cash on hand

Cash · fiscal 2025
$312.82M

ArriVent BioPharma, Inc. (AVBP) held cash of $312.82M at the end of fiscal 2025 (December 31, 2025). That is 42.9% higher than the $218.86M of fiscal 2024. Figures as of 18 Nov 2026, 03:07 UTC, from Yahoo Finance.

Key facts

Cash, fiscal 2025
$312.82M
Change on fiscal 2024
+42.9%
Highest on record
$312.82Mfiscal 2025
Lowest on record
$150.39Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

ArriVent BioPharma, Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $312.82M in fiscal 2025 and the lowest $150.39M in fiscal 2023.

History · 4 fiscal years

Cash by fiscal year

ArriVent BioPharma, Inc. cash on hand, year by year

ArriVent BioPharma, Inc. (AVBP) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$312.82M 42.9% up
2024$218.86M 45.5% up
2023$150.39M 7.9% down
2022$163.37M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on AVBP

ArriVent BioPharma, Inc., figure by figure

ArriVent BioPharma, Inc. (AVBP) overview: price, valuation and scorecard

ArriVent BioPharma, Inc. cash on hand: questions and answers

How much cash does ArriVent BioPharma, Inc. have?

ArriVent BioPharma, Inc. (AVBP) held cash of $312.82M at the end of fiscal 2025 (December 31, 2025). That is 42.9% higher than the $218.86M of fiscal 2024.

What are the highest and lowest cash figures on record for ArriVent BioPharma, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $312.82M in fiscal 2025 and the lowest $150.39M in fiscal 2023.

How is ArriVent BioPharma, Inc.'s cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ArriVent BioPharma, Inc. (AVBP) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/AVBP/cash

Underlying data: Yahoo Finance.